{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"8.880","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"348,370,511","primaryexch":"香港交易所","ric":"2487.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BRJXCB3","am":"2.38","iv":"","ew_strike":"","as":"8.810","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"8.730","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"200","update_time":"2025-09-28 00:06:03.0","lo52":"3.640","shares_issued_date":"2025年9月5日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"陳連勇","underlying_ric":"2487.HK","hi52":"18.260","issuer_name":"科笛集團 - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"8.580","mkt_cap":"3.04","f_aum_hkd":null,"ew_sub_per_to":"","ls":"8.730","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.060","aum":"","issued_shares_class_B":null,"vo":"274.20","secondary_listing_flag":false,"listing_date":"2023年6月12日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"科笛集團 - B","nm_s":"科笛－Ｂ","sym":"2487","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"科笛集團是一家主要從事皮膚學生物製藥業務的投資控股公司。該公司致力於皮膚病治療及護理市場中開發解決方案，涵蓋毛髮疾病及護理、皮膚疾病及護理、表皮麻醉以及局部脂肪堆積管理。該公司主要從事毛髮疾病及護理產品以及若干護膚產品的分銷。該公司的主要管線產品包括外用非那雄胺噴霧劑CU-40102、外用4%米諾環素泡沫劑CU-10201、外用新型小分子藥劑CU-10101、局部外用利多卡因丁卡因乳膏劑CU-30101和重組突變膠原酶CU-20401。","op":"8.790","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港銅鑼灣<br/>勿地臣街1號<br/>時代廣場二座<br/>31樓","pc":"-0.68","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"8.790","isin":"KYG2606C1006","moneyness":""}},"qid":"1759074526209"}
